|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 29.44 USD | -0.99% |
|
-4.12% | +40.62% |
| Jul. 15 | Phibro Animal Health Corporation Presents at Barclays 27th Annual Global Healthcare Conference 2025, Mar-13-2025 09:00 AM | |
| Jul. 07 | Phibro Animal Health Shares Rise After JP Morgan Upgrade | MT |
| Capitalization | 1.21B 1.04B 970M 899M 1.66B 104B 1.86B 11.75B 4.43B 48.55B 4.52B 4.43B 179B | P/E ratio 2025 * |
27.3x | P/E ratio 2026 * | 19.4x |
|---|---|---|---|---|---|
| Enterprise value | 1.79B 1.55B 1.44B 1.34B 2.46B 154B 2.76B 17.48B 6.58B 72.19B 6.72B 6.58B 266B | EV / Sales 2025 * |
1.4x | EV / Sales 2026 * | 1.21x |
| Free-Float |
49.93% | Yield 2025 * |
1.61% | Yield 2026 * | 1.61% |
More valuation ratios
* Estimated data
More news
Last Transcript: Phibro Animal Health Corporation
More recommendations
More press releases
| 1 day | -2.65% | ||
| 1 week | -4.53% | ||
| Current month | +16.41% | ||
| 1 month | +21.60% | ||
| 3 months | +71.95% | ||
| 6 months | +42.80% | ||
| Current year | +41.57% |
| 1 week | 29.64 |  | 31.71 |
| 1 month | 23.57 | | 31.8 |
| Current year | 16.16 | | 31.8 |
| 1 year | 16.16 | | 31.8 |
| 3 years | 9.4 | | 31.8 |
| 5 years | 9.4 | | 31.8 |
| 10 years | 9.4 | | 54.62 |
| Manager | Title | Age | Since |
|---|---|---|---|
Jack Bendheim
CEO | Chief Executive Officer | 78 | 2014-02-28 |
Glenn David
DFI | Director of Finance/CFO | 53 | 2024-02-08 |
| Chief Tech/Sci/R&D Officer | 49 | - |
| Director | Title | Age | Since |
|---|---|---|---|
Jack Bendheim
CHM | Chairman | 78 | 2002-04-30 |
Daniel Bendheim
BRD | Director/Board Member | 53 | 2013-10-31 |
E. Corcoran
BRD | Director/Board Member | 78 | 2008-04-30 |
| Name | Weight | AuM | 1st Jan change | |
|---|---|---|---|---|
| 0.33% | 23 M€ | -4.35% | - | |
| 0.32% | 29 M€ | -2.42% | - |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -2.65% | -4.53% | +56.31% | +48.43% | 1.21B | ||
| -1.00% | -5.52% | -17.59% | -14.04% | 66.79B | ||
| +3.10% | -0.53% | +14.64% | -25.50% | 7.43B | ||
| +2.27% | +1.95% | -8.31% | +7.35% | 3.71B | ||
| +0.99% | +5.13% | +2.43% | -2.18% | 3.45B | ||
| -13.98% | -11.35% | +3.84% | -9.09% | 2.33B | ||
| +1.68% | +12.63% | +63.06% | +27.11% | 1.38B | ||
| +4.59% | +10.50% | +21.27% | -29.59% | 1.17B | ||
| -0.50% | +2.18% | -22.32% | -36.75% | 1.09B | ||
| -0.18% | +3.70% | +22.41% | -34.33% | 1.07B | ||
| Average | -0.39% | +2.18% | +13.57% | -6.86% | 8.96B | |
| Weighted average by Cap. | +0.62% | -3.65% | -10.04% | -12.77% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 1.28B 1.1B 1.03B 953M 1.76B 110B 1.97B 12.47B 4.69B 51.5B 4.79B 4.7B 190B | 1.44B 1.25B 1.16B 1.08B 1.98B 124B 2.23B 14.08B 5.3B 58.15B 5.41B 5.3B 214B |
| Net income | 44.3M 38.22M 35.65M 33.03M 60.9M 3.81B 68.33M 432M 163M 1.78B 166M 163M 6.58B | 62.49M 53.92M 50.29M 46.59M 85.9M 5.38B 96.39M 610M 229M 2.52B 234M 230M 9.28B |
| Net Debt | 587M 506M 472M 438M 807M 50.49B 905M 5.72B 2.16B 23.64B 2.2B 2.16B 87.15B | 545M 470M 439M 406M 749M 46.89B 841M 5.32B 2B 21.95B 2.04B 2B 80.93B |
More financial data
* Estimated data
Employees
1,940
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 25-07-18 | 29.44 $ | -0.99% | 76,842 |
| 25-07-17 | 29.73 $ | -2.65% | 371,328 |
| 25-07-16 | 30.54 $ | -0.07% | 262,614 |
| 25-07-15 | 30.56 $ | -3.11% | 295,845 |
| 25-07-14 | 31.54 $ | +2.40% | 335,761 |
Delayed Quote Nasdaq, July 17, 2025 at 04:00 pm EDT
More quotes
Sell
Buy
Mean consensus
HOLD
Number of Analysts
4
Last Close Price
29.73USD
Average target price
26.00USD
Spread / Average Target
-12.55%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- PAHC Stock
Select your edition
All financial news and data tailored to specific country editions
